Background/Aims: Continuous renal replacement therapy (CRRT) is commonly used for critically ill patients with acute kidney injury. During treatment, a slow dialysate flow rate can be applied to enhance diffusive solute removal. However, due to the lack of the rationale of the dialysate flow configuration (countercurrent or concurrent to blood flow), in clinical practice, the connection settings of a hemodiafilter are done depending on nurse preference or at random. Methods: In this study, we investigated the effects of flow configurations in a hemodiafilter during continuous venovenous hemodialysis on solute removal and fluid transport using computational fluid dynamic modeling. We solved the momentum equation coupling solute transport to predict quantitative diffusion and convection phenomena in a simplified hemodiafilter model. Results: Computational modeling results showed superior solute removal (clearance of urea: 67.8 vs. 45.1 ml/min) and convection (filtration volume: 29.0 vs. 25.7 ml/min) performances for the countercurrent flow configuration. Countercurrent flow configuration enhances convection and diffusion compared to concurrent flow configuration by increasing filtration volume and equilibrium concentration in the proximal part of a hemodiafilter and backfiltration of pure dialysate in the distal part. In clinical practice, the countercurrent dialysate flow configuration of a hemodiafilter could increase solute removal in CRRT. Nevertheless, while this configuration may become mandatory for high-efficiency treatments, the impact of differences in solute removal observed in slow continuous therapies may be less important. Under these circumstances, if continuous therapies are prescribed, some of the advantages of the concurrent configuration in terms of simpler circuit layout and simpler machine design may overcome the advantages in terms of solute clearance. Conclusion: Different dialysate flow configurations influence solute clearance and change major solute removal mechanisms in the proximal and distal parts of a hemodiafilter. Advantages of each configuration should be balanced against the overall performance of the treatment and its simplicity in terms of treatment delivery and circuit handling procedures.

Keywords:
Acute kidney injury, Computational fluid dynamics, Continuous renal replacement therapy, Convection, Dialysis solutions, Diffusion, Solute clearance, Ultrafiltration
1.
Claure-Del Granado R, Macedo E, Chertow GM, Soroko S, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL: Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis. Clin J Am Soc Nephrol 2011;6:467–475.
2.
Keener J, Sneyd J: Renal physiology; in Keener J, Sneyd J (eds): Mathematical Physiology. Berlin, Springer, 1998, pp 421–450.
3.
Ould-Dris A, Paullier P, Griscom L, Legallais C, Leclerc E: Analysis of the mass transfers in an artificial kidney microchip. J Membr Sci 2010;352:116–125.
4.
Eloot S, De Vos JY, Hombrouckx R, Verdonck P: Diffusive clearance of small and middle-sized molecules in combined dialyzer flow configurations. Int J Artif Organs 2004;27:205–213.
5.
Davenport A, Will EJ, Davison AM: Effect of the direction of dialysate flow on the efficiency of continuous arteriovenous haemodialysis. Blood Purif 1990;8:329–336.
6.
Liao Z, Klein E, Poh CK, Huang Z, Hardy PA, Morti S, Clark WR, Gao D: A modified equivalent annulus model for the hollow fiber hemodialyzer. Int J Artif Organs 2004;27:110–117.
7.
Colton CK, Smith KA, Merrill ER, Friedman S: Diffusion of urea in flowing blood. AIChE J 1971;17:800–808.
8.
Valencia DP, González FJ: Understanding the linear correlation between diffusion coefficient and molecular weight. A model to estimate diffusion coefficients in acetonitrile solutions. Electrochem Commun 2011;13:129–132.
9.
Young ME, Carroad PA, Bell RL: Estimation of diffusion coefficients of proteins. Biotechnol Bioengin 1980;22:947–955.
10.
Raff M, Welsch M, Göhl H, Hildwein H, Storr M, Wittner B: Advanced modeling of highflux hemodialysis. J Membr Sci 2003;216:1–11.
11.
Floris M, Marchionna N, Clementi A, Kim JC, Cruz DN, Nalesso F, Zanella M, Garzotto F, de Cal M, Virzi GM, Brendolan A, Ronco C: Evaluation of a new polysulfone hemofilter for continuous renal replacement therapy. Blood Purif 2011;32:133–138.
12.
Ronco C, Brendolan A, Crepaldi C, Rodighiero M, Scabardi M: Blood and dialysate flow distributions in hollow-fiber hemodialyzers analyzed by computerized helical scanning technique. J Am Soc Nephrol 2002;13(suppl 1):S53–S61.
13.
Huang Z, Gao D, Letteri JJ, Clark WR: Blood-membrane interactions during dialysis. Semin Dial 2009;22:623–628.
14.
Vesconi S, Cruz DN, Fumagalli R, Kindgen-Milles D, Monti G, Marinho A, Mariano F, Formica M, Marchesi M, Rene R, Livigni S, Ronco C: Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 2009;13:R57.
15.
Venkataraman R, Kellum JA, Palevsky P: Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States. J Crit Care 2002;17:246–250.
16.
Kurusz M, Butler B, Katz J, Conti VR: Air embolism during cardiopulmonary bypass. Perfusion 1995;10:361–391.
17.
Forsberg U, Jonsson P, Stegmayr C, Stegmayr B: Microemboli, developed during haemodialysis, pass the lung barrier and may cause ischaemic lesions in organs such as the brain. Nephrol Dial Transplant 2010;25:2691–2695.
18.
Stegmayr C, Jonsson P, Forsberg U, Stegmayr B: Hemodialysis dialyzers contribute to contamination of air microemboli that bypass the alarm system in the air trap. Int J Artif Organs 2008;31:317–322.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.